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Rationale: Exposures to simulated altitude (normobaric hypoxia, NH) are frequently
used in preparation for mountaineering activities at real altitude (hypobaric hypoxia, HH).
However, physiological responses to exercise in NH and HH may differ. Unfortunately
clinically useful information on such differences is largely lacking. This study therefore
compared exercise responses between a simulated hike on a treadmill in NH and a similar
field hike in HH.
Methods: Six subjects (four men) participated in two trials, one in a NH chamber and
a second in HH at an altitude of 4,205m on the mountain Mauna Kea. Subjects hiked
in each setting for 7 h including breaks. In NH, hiking was simulated by walking on a
treadmill. To achieve maximal similarity between hikes, subjects used the same nutrition,
clothes, and gear weight. Measurements of peripheral oxygen saturation (SpO2), heart
rate (HR) and barometrical pressure (PB)/inspired oxygen fraction (FiO2) were taken
every 15 min. Acute mountain sickness (AMS) symptoms were assessed using the
Lake-Louise-Score at altitudes of 2,800, 3,500, and 4,200 m.
Results: Mean SpO2 values of 85.8% in NH were significantly higher compared to those
of 80.2% in HH (p = 0.027). Mean HR values of 103 bpm in NH were significantly lower
than those of 121 bpm in HH (p= 0.029). AMS scores did not differ significantly between
the two conditions.
Conclusion: Physiological responses to exercise recorded in NH are different from those
provoked by HH. These findings are of clinical importance for subjects using simulated
altitude to prepare for activity at real altitude.
Trial registration: Registration at DRKS. (Approval No. 359/12, Trial No.
DRKS00005241).
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INTRODUCTION
The popularity of using normobaric hypoxia (NH) to
prepare for hypobaric hypoxia (HH) experienced during
mountaineering activities at real altitude raises the question
about the comparability between the effects of NH and HH.
The primary condition that differs between NH and HH is
the mechanism by which partial pressure of inspired oxygen
(PiO2) is reduced, with PiO2 defined as inspired oxygen fraction
(FiO2) × (PB-47 mmHg). Reductions in PiO2 can be achieved
by altering the barometric pressure (PB) in HH or the inspired
fraction of oxygen (FiO2) in NH (Conkin and Wessel, 2008).
Since seminal work by Paul Bert in 1878, lower PiO2 has been
assumed to be the primary stimulus for adapting to any hypoxic
state (Bert, 1878; Conkin and Wessel, 2008). More recently, a
direct relationship between lower arterial partial pressure of
carbon dioxide (PaCO2) and the reduction of PB was found,
proposing a synergistic effect of environmental pressure and
FiO2 (Saltzman et al., 1971; Savourey et al., 2003). This effect
has been used to explain differences regarding the physiological
responses in HH compared to NH environments (Tucker et al.,
1983; Roach et al., 1996; Loeppky et al., 2005).
Peripheral oxygen saturation (SpO2) and arterial blood
oxygen saturation (SaO2) have been found to be significantly
lower in HH compared to NH. This has been speculated to be
due to increased dead space ventilation, provoked by a lower
tidal volume (Vt) and a higher breathing frequency (f ) (Savourey
et al., 2003, 2007). Accordingly, PaCO2 decreases with alkalemia
as a consequence, shifting the oxyhemoglobin dissociation curve
to the left (Savourey et al., 2003). A recent review describes the
variations in ventilation in NH and HH (Coppel et al., 2015). The
heart rate (HR) is increased in HH (Savourey et al., 2007; Self
et al., 2011; Faiss et al., 2013). The severity of acute mountain
sickness (AMS) as a result of physiological differences in HH
appears to be greater as well (Tucker et al., 1983; Roach et al.,
1996; Loeppky et al., 2005).
After years of altitude research most differences between NH
and HH appear to be sufficiently explored.
However, one aspect that is still debated is the
interchangeability of the HH and NH environments regarding
their effects on physiological responses. Previous studies often
lack standardization or detailed documentation and do not
provide comparability of study designs (Millet et al., 2012a,b;
Mounier and Brugniaux, 2012; Saugy et al., 2016). Most of the
studies conducted used laboratory settings for both NH and HH
(Millet et al., 2012a) Since the advent of chamber research on
hypoxia, questions have remained regarding the comparability
between conditions of the simulated chamber environment and
the real-life mountain environment.
According to a recent review, several studies have compared
NH and HH but the comparison of laboratory (NH) and field
(HH) environments in a single standardized study has not yet
been performed (Coppel et al., 2015). To show differences in
SpO2, HR, and AMS between laboratory NH and field HH
conditions we conducted measurements of these parameters
during a hike in simulated altitude and again in real altitude,
standardizing variables as much as possible to allow for maximal
comparability over the course of a 7-h exposure time. We
hypothesized that we could verify the significant differences in
SpO2, HR, and AMS previously reported by other researchers
from laboratory research and research at fixed altitudes by
performing a study protocol with continuously increasing
altitude in the field.
METHODS
Subjects
Six healthy participants who usually resided at an altitude
between 500 and 650m (4 men and 2 women, ages 24–45
years) were recruited for the study. They were students of the
Department of Sports Science of the University of Innsbruck and
reported a moderate fitness routine of 1–4 h per week of training
in various disciplines. Descriptive characteristics of participants
are shown in Table 1. All subjects gave their written informed
consent prior to the participation in the study. None of the
participants had been at an altitude above 2,000m for 6 months
prior to the study.
Protocol
Participants completed two trials (T1 and T2). T1 took place
in a normobaric hypoxia chamber. Normobaric hypoxia was
provided by an oxygen expulsion system (Low Oxygen Systems;
Berlin-Buch, Germany). The expulsion system (oxygen exchange
through nitrogen) allows a mixture of fresh air to keep controlled
CO2 levels comparable to the levels measured in HH. Four
weeks after the first trial, participants went through an equivalent
testing protocol (T2) under hypobaric hypoxia conditions on the
mountain Mauna Kea, Hawaii, USA. Mauna Kea was chosen
for the experiment for a number of important reasons. The
mountain’s altitude with a moderate continuous inclination
allowed the simulated treadmill hike to be programmed to a
high degree of comparability. Constant climatic conditions on
the mountain with temperatures around 20◦C paralleled the
temperatures in the normobaric hypoxia room. Road access
to the summit facilitated transport of gear and descent of the
participants. Participants were asked to wear the same clothes
and use the same equipment during each trial. The amount of
food and beverage intake was weighed and recorded for each
person at breakfast and dinner before T1. The subjects were
instructed to follow the same food and beverage intake in T2.
Participants carried the same weight consisting of snacks and
beverage in a backpack during both trials. Energy and fluid intake
were measured individually during T1 and kept the same for T2.
Temperature and humidity were continually measured in both
settings.
T1 Protocol
The first trial in NH conditions (T1) involved a 7-h stay in the
chamber with 6 h walking on a treadmill (h/p Cosmos Mercury
and Quasar). The built-in calibrating sensor of the treadmills
were checked for accuracy by a mechanic prior to testing (error
< 0.2m per 100-m interval). The treadmill hike was set at an
average incline of 14.2% and a constant speed of 1.6 km/h. These
parameters were calculated to simulate the hike on top of the
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TABLE 1 | Subjects’ Characteristics.
Subject Sex (m/f) Age (yr) Height (cm) Weight (kg) Weight + backpack (kg) BMI (kg/m2)
1 f 24 169 66 73 23.1
2 m 25 180 62 76 19.1
3 f 26 174 68 71 22.4
4 m 25 174 72 84 23.8
5 m 25 189 82 91 22.9
6 m 45 175 75 81.4 24.5
Mean Values ± SD 28.3 ± 8.2 176.8 ± 6.9 70.8 ± 7.1 79.2 ± 7.5 22.6 ± 1.9
Mauna Kea Mountain. The average incline was determined as
the ratio between the difference in altitude (1,405m) and the
walking distance (9,894m). The treadmill speed was calculated
as a function of the duration of walking (6 h) and the walking
distance. Participants started walking at a simulated altitude of
2,800m. The FiO2 in the chamber was modified automatically,
which led to the completion of the treadmill task at a simulated
altitude of 4,200m. During the testing, participants had 3 breaks;
a 15-min break after 75min of walking, a 30-min break after
195min of walking and another 15-min break after 315min of
walking. During the breaks, participants stayed in the chamber,
resting, drinking, and eating snacks. An investigator was present
throughout all testing in NH, controlling the simulated altitude,
time, walking distance, and FiO2 (measured by O2 and CO2
probes in the room, Dräger Germany).
T2 Protocol
In the second trial, participants arrived on the Big Island Hawaii
and rested for 4 days after arrival with at least 8 h of sleep
per night. Participants then hiked the Humu’ula trail on top
of the Mauna Kea Mountain. The subjects were brought to the
starting point of the hike via a 30-min car drive. The experiment
started at 09:00 AM local lime. The trail starts at an altitude of
2,800m and ends at 4,200m. Participants used a GPS receiver
(Forerunner R© 305, Garmin, Garching, Germany) to measure
time and walking distance. The PM 90 monitor (Beurer GmbH,
Ulm, Germany) was used to evaluate barometric pressure and
altitude as well as to keep a constant walking speed. We report
each 15-min measurement interval as 50m in altitude gain. Two
15-min breaks and one 30-min break were made after the same
time of walking as in T1. Participants rested, ate snacks and drank
fluids during the breaks just as in T1.
Measurements
Anthropometric measurements were made and participants were
weighed with and without their backpacks before T1. For at
least 1min every 15min during the hike, measurements of
HR and SpO2 were conducted by the participants themselves.
The measurements were done using fingertip pulse oximeters
(PULOX R© PO-100, Novidion GmbH, Cologne, Germany,
accuracy for SpO2 = 70–100 ± 2% and for HR = 30–250
± 2 beats per min). Participants avoided solar radiation on
the devices and noted the stable SpO2 at the end of the
1min measurement (Luks and Swenson, 2011). Self-reported
recordings were visually checked by one investigator and one
other participant independently for possible artifacts. Only one
value, a SpO2 in subject 5, had to be corrected. The rate of
perceived exertion was assessed via Borg scale directly after the
hike.
Subjective symptoms of AMS were assessed using the
Lake-Louise-Score (LLS) Questionnaire at altitudes if 2,800,
3,500, and 4,200m (Roach et al., 1993). The following AMS
categories were assessed: (1) headache, (2) gastrointestinal
symptoms (e.g., nausea), (3) fatigue and/or weakness, (4)
dizziness/lightheadedness. According to the literature, the 5th
symptom complex of the LLS, i.e., the quality of sleep, was
excluded from the self-report section (Macinnis et al., 2013).
Participants rated the severity of AMS symptoms from 0 (no
discomfort) to 3 (severe discomfort). AMS was diagnosed when
headache occurred together with one other symptom from the
categories mentioned above, and a total LLS of >3 (Hackett and
Roach, 2001). Walking time, distance, speed, and altitude were
assessed the same way in T1 and T2.
Statistics
Although sample size was primarily based on logistical
considerations, a power analysis was performed with G-Power
Version 3.1.9.2 (University of Kiel) for dependent samples
(correlation coefficient set at 0.5) with expected values of
mean SpO2 90 ± 3% for NH and 85 ± 3% for HH based
on previous study results (Savourey et al., 1997, 2003, 2007;
Boos et al., 2016). The power analysis yielded a sample size
of six subjects. Statistical analysis was performed using IBM
SPSS Statistics 23 (PASW Statistics for Windows version 21.0,
SPSS Inc., Chicago, IL, USA). Data were expressed as means
and standard deviations or as medians with 95% confidence
intervals as appropriate. Nonparametric tests (Wilcoxon) were
used for HR, SpO2, and AMS scores at each time point
comparing NH and HH. The significance threshold was set at
0.05.
Study Approval
The Ethics Committee at the Leopold-Franzens-University of
Innsbruck, Austria approved the study protocol on the October
1, 2014. Participants gave their written informed consent prior to
inclusion in the study.
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RESULTS
All participants completed the two exposure trials successfully.
During ascent in NH, FiO2 was lowered continuously from
14.6% at 2,800m, 13.2% at 3,500m to 12.1% at 4,205m (PB
= 767.3mmHg). The room air CO2 concentration was kept
relatively constant during the experiment at 884 ppm ± 325
within limits that did not influence ventilation. On the mountain,
PB was measured with a value of 550mmHg at 2,800m,
496mmHg at 3,500m and 465mmHg at 4,205m (Figure 1).
Temperature ranged in both conditions (at Mauna Kea between
sunrise and sunset) at all altitude levels around 20◦C (19–24◦C)
and humidity was between 50 and 60% (average on Mauna Kea
58%; in the chamber 55%). Wind speed onMauna Kea was below
5mph.
An overall statistical difference between NH and HH
regarding HR and SpO2 was detected (p < 0.05; Tables 2, 3).
However, AMS scores did not differ significantly between the
chamber and the mountain. Self-reported Borg scale values
showed no difference (p = 1.00) for rate of perceived exertion
in both NH (12.33± 2.07) and HH (12.33± 1.75).
Heart Rate
The HR showed significant differences in 66% of the measured
time points between NH and HH (p-values varied from p =
0.027–0.046, Table 2). In both NH and HH, the lowest values of
individual HR were observed during or after the three walking
breaks around 3,100, 3,500, and 3,900m (Figure 2). Minimum
HR values ranged from 53 to 93 beats per min (bpm) in
NH and from 68 to 103 bpm in HH. Peak values extended
from 106 to 137 bpm in NH and from 130 bpm to 159
in HH.
Peripheral Oxygen Saturation
Significant differences in SpO2 were seen between NH and HH
in 62% of the measured time points (Table 3). Most significant
p-values for SpO2 were detected (p-values ranged from p =
0.027–0.046) from 3,100 to 3,300m and from 3,750 to 4,000m.
The SpO2 values for each participant decreased with increasing
altitude (Figure 3). Highest values of SpO2 were reached during
or after the 3 breaks around 3,100, 3,500, and 3,900m. Peak
values ranged from 95 to 97% in NH and from 93 to 95% in HH.
Lowest SpO2 values ranged from 68 to 82% in NH and from 61
to 75% in HH.
In the two women (subjects 1 and 3), SpO2 in HH was higher
compared to NH around the break at 3,500mwith values ranging
from 90 to 93% in HH compared to 88 and 91% in NH. Subjects
2 and 6 were the only participants in whom the SpO2 values in
HH were lower throughout the whole protocol except for the
beginning at 2,800m. In subject 6, the SpO2 values stayed higher
in HH up to 3,050m. Subject 5 randomly showed one higher
SpO2 value of 85% in HH compared to 82% in NH at 3,700m.
Therefore, we consider the one time measurement of 61% at
3,950m an artifact. The largest difference in SpO2 values was
found in subject 4 varying from 95% at 2,800m to 60% at 3,850
and 4,150m in HH.
Acute Mountain Sickness
There was no significant difference in AMS scores examined (p>
0.05) between NH and HH. The severity of AMS was mild (LLS
3 to 4) in almost all subjects in both NH and HH. On average,
median AMS scores were lower than 3, except for the increased
median value of 3.5 at an altitude of 4,200m in HH which is
not statistically significant. Half of the subjects reported an AMS
FIGURE 1 | Comparison of inspired oxygen (PiO2) and peripheral oxygen saturation (SpO2) during the hikes in normobaric hypoxia (NH) and hypobaric
hypoxia (HH). Legend: Break 1 at 3,100m altitude, Break 2 at 3,500m altitude, Break 3 at 3,900m altitude; % = SpO2%; mmHg = PiO2 mmHg.
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TABLE 2 | Actual fraction of inspired oxygen (FiO2) in normobaric
hypoxia (NH) and barometric pressure (PB) in hypobaric hypoxia (HH).






Altitude (m) HR median (bpm) and 95% CI NH vs. HH
NH HH p-value
14.57 550 2,800 93 (77–109) 87 (72–102) 0.225
14.57 566 2,850 108 (100–115) 123 (109–137) 0.028
14.33 539 2,900 104 (93–114) 110 (93–126) 0.249
14.25 533 2,950 101 (91–111) 122 (101–143) 0.046
14.21 527 3,000 102 (89–114) 120 (104–136) 0.027
14.02 523 3,050 103 (91–114) 125 (109–140) 0.027
13.89 518 3,100 103 (88–118) 122 (112–131) 0.027
13.85 518 3,150 84 (69–99) 94 (76–111) 0.080
13.66 516 3,200 103 (92–114) 131 (114–148) 0.028
13.56 509 3,250 104 (95–113) 122 (105–139) 0.028
13.50 506 3,300 105 (94–116) 122 (96–148) 0.028
13.46 503 3,350 104 (94–114) 125 (107–142) 0.027
13.24 500 3,400 103 (90–115) 129 (108–149) 0.028
13.24 497 3,450 105 (93–116) 133 (112–153) 0.028
13.21 496 3,500 80 (62–98) 87 (68–105) 0.115
13.18 496 3,550 75 (59–90) 87 (69–105) 0.046
12.97 493 3,600 107 (95–119) 130 (96–164) 0.173
12.91 489 3,650 111 (97–124) 131 (114–148) 0.027
12.80 486 3,700 109 (91–126) 135 (105–165) 0.046
12.69 483 3,750 109 (92–126) 128 (115–141) 0.028
12.63 478 3,800 111 (93–128) 136 (120–152) 0.027
12.52 476 3,850 110 (93–127) 138 (118–158) 0.028
12.49 476 3,900 87 (67–107) 94 (77–111) 0.058
12.37 476 3,950 112 (94–129) 126 (91–161) 0.173
12.33 473 4,000 113 (95–131) 122 (108–136) 0.115
12.26 470 4,050 115 (98–132) 115 (96–133) 0.345
12.10 467 4,100 121 (106–135) 125 (106–144) 0.173
12.08 465 4,150 114 (93–134) 132 (107–157) 0.046
12.03 465 4,200 114 (92–135) 130 (105–155) 0.046
Mean 103 (93–114) 121 (106–135)
severity of 4 at 4,200m in HH, whereas one participant suffered
from mild AMS (LLS = 4) at a lower altitude of 3,500m on the
mountain. Two subjects experienced a LLS ≥ 3 in NH. None
of the participants noted severe nausea and vomiting or severe
fatigue or dizziness.
DISCUSSION
This is the first study to compare a 7-h simulated high altitude
hike in a normobaric hypoxia chamber and a mountain hike
at real altitude. This study provides a descriptive comparison
of physiological parameters (HR and SpO2) and AMS scores
measured in a chamber (NH) and on the mountain (HH).
Our findings do verify previously reported differences for SpO2
and HR, with SpO2 values significantly lower and HR values
TABLE 3 | Fractions of inspired oxygen (FiO2) in normobaric hypoxia (NH),
barometric pressure (PB) in hypobaric hypoxia (HH), medians (confidence






Altitude (m) SpO2 median (%) and 95% CI NH vs. HH
NH HH p-value
14.57 550 2,800 93 (91–95) 94 (92–96) 0.336
14.57 566 2,850 93 (91–94) 92 (88–95) 0.399
14.33 539 2,900 93 (90–95) 92 (89–95) 0.248
14.25 533 2,950 91 (89–93) 91 (85–96) 0.786
14.21 527 3,000 90 (88–92) 90 (85–94) 0.854
14.02 523 3,050 91 (86–95) 86 (83–88) 0.078
13.89 518 3,100 91 (85–97) 84 (79–88) 0.027
13.85 518 3,150 94 (90–97) 89 (86–92) 0.027
13.66 516 3,200 89 (84–94) 81 (75–86) 0.028
13.56 509 3,250 89 (85–93) 80 (78–82) 0.026
13.50 506 3,300 88 (83–93) 83 (78–87) 0.026
13.46 503 3,350 87 (82–92) 81 (75–87) 0.058
13.24 500 3,400 87 (82–92) 81 (75–86) 0.172
13.24 497 3,450 86 (81–91) 79 (72–85) 0.046
13.21 496 3,500 91 (88–93) 84 (79–89) 0.028
13.18 496 3,550 90 (86–94) 84 (75–92) 0.075
12.97 493 3,600 84 (79–89) 74 (68–80) 0.027
12.91 489 3,650 83 (77–88) 76 (71–81) 0.027
12.80 486 3,700 83 (78–88) 78 (72–83) 0.112
12.69 483 3,750 82 (77–87) 76 (70–82) 0.027
12.63 478 3,800 81 (75–87) 74 (70–78) 0.027
12.52 476 3,850 80 (75–85) 73 (64–82) 0.046
12.49 476 3,900 84 (79–88) 76 (64–87) 0.028
12.37 476 3,950 80 (74–86) 68 (61–75) 0.027
12.33 473 4,000 80 (73–86) 73 (71–74) 0.046
12.26 470 4,050 79 (74–84) 75 (70–80) 0.058
12.10 467 4,100 79 (74–84) 73 (67–78) 0.027
12.08 465 4,150 77 (71–82) 71 (64–78) 0.027
12.03 465 4,200 77 (71–82) 73 (68–78) 0.027
Mean 86 (82–90) 80.2 (77–83)
significantly higher in a HH environment compared to NH.
However, in contrast to prior reports, AMS severity did not differ
significantly between the two settings.
Using a study design similar to our protocol, Savourey
et al. also found SpO2 to be significantly lower in a hypobaric
chamber (HH) compared to NH with a simulated altitude
exposure to 4,500m (Savourey et al., 2003). The Savourey
study was performed at a fixed altitude for a limited time
only. However, ventilation was measured and revealed increased
dead space ventilation in HH due to a lower tidal volume
(Vt) and a higher frequency of breathing (f ). This breathing
pattern caused a lower PaCO2, alkalemia, and a lower SpO2
than in NH (Savourey et al., 2003). Other studies reported a
direct relationship between a lower PaCO2 and the reduction
of PB (Saltzman et al., 1971). To explain the findings of
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FIGURE 2 | Comparison of individuals’ heart rate (HR) in normobaric hypoxia (NH) and hypobaric hypoxia (HH).
significantly lower SaO2 values in HH compared to NH at a
simulated altitude of 7,620m a synergistic effect of hypoxia
and hypobaria was proposed (Levine et al., 1988; Self et al.,
2011).
The studies cited above were characterized by a short
exposure time to hypoxia (<1 h) at fixed altitudes. The
importance of exposure time was emphasized in a review
of five long-term hypoxia exposure studies (>1 h) which
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FIGURE 3 | Comparison of individual’s peripheral oxygen saturation (SpO2) between normobaric hypoxia (NH) and hypobaric hypoxia (HH).
did not show any differences in SpO2 between NH and
HH,(Tucker et al., 1983; Roach et al., 1996; Loeppky et al.,
1997, 2005; Faiss et al., 2013) possibly due to acclimatization
to hypoxia (Coppel et al., 2015). What sets our study apart
from prior research is that the study design incorporated a
long exposure time at increasing altitudes with movement
and exercise performance utilizing actual mountaineering
conditions.
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Subjects 1 and 3 reacted with values ranging from 90 to 93%
in HH compared to 88 and 91% in NH around the 3,500m break.
Because both participants were women, a likely explanation of
this finding may be increased respiratory drive due to higher
progesterone levels in these participants.
In previous short-term as well as in long-term exposure
studies, heart rate values tended to be higher in HH, but showed
inconsistent results compared to NH (Savourey et al., 1997). In
their first study, Savourey et al. recorded HR values that were
significantly higher in HH, whereas in their second study no
significant differences in HR were found, despite using a very
similar protocol (Savourey et al., 2003, 2007). While the subjects
of Savourey et al. were exposed to altitude for only 40 min, Faiss
et al. conducted a 24-h exposure study at 3,000m and did not
find any significant differences in HR at rest or during moderate
physical activity between conditions of NH and HH (Faiss et al.,
2013). In our study HR was significantly higher in HH for the
duration of 7 h. The increased HR values may be explained by a
need for higher cardiac output due to a lower minute ventilation
(VE) from faster and shallower breathing in HH as has often
reported in studies (Savourey et al., 2007; Self et al., 2011; Faiss
et al., 2013).
There are other possible explanations for the increased
HR we demonstrated during the mountain trail hike: (a) the
ground surface on the Humu’ula trail is uneven compared to a
treadmill and could have elicited higher exercise performance, (b)
ultraviolet light radiation of the sun could have led increased fluid
loss on the mountain trail compared to the chamber conditions.
With restrictions on fluid intake to maintain comparability of
intake between study settings, volume depletion with consequent
tachycardia may have occurred, and (c) participants reported
marked differences in group dynamics between the settings with
more group pressure on Mauna Kea.
Our finding regarding the lack of difference in severity of AMS
symptoms between NH and HH agrees with previous research
(Richard et al., 2014). There are two factors that affect the
generalizability of this finding. First, there was high inter-subject
variability with the LLS probably due to the subjective nature of
this questionnaire. Second, AMS becomes fully manifest after 6–
96 h of hypoxic exposure at moderate to high altitudes (Debevec
and Millet, 2014) Therefore, the 7-h exposure duration used in
our study design may have had an impact on the participants’
experiences of AMS during NH and HH. Limited exposure
durationmay explain the discrepancies between our observations
and those studies reporting the opposite finding with exposure
durations longer than 8 h (Debevec and Millet, 2014).
As is true of all studies with high altitude field observations,
our study has limitations. Due to logistical problems, it was
not possible to randomize assignments to the different study
stages. It was also not possible to blind subjects to the
experimental conditions in this crossover trial comparing NH
in a chamber with natural HH on a mountain. However, due
to the fact that the study results are based predominantly on
objective parameters as SpO2 and heart rate the likelihood
of influencing results with personal bias is low. A minor
limitation is the potential confounding effect of hypobaric
acclimatization during the flights to Hawaii (10 and 5 h with
14 h lay-over between flights) as well as the jetlag effect on
circadian rhythms. However, 4 days of rest at sea level on
Hawaii with extended sleep times and time for sun exposure
on the beach diminished these potential cofounding effects
(Reilly and Edwards, 2007). Another minor limitation is that
we did not measure urine concentrations after the hikes
such that we cannot determine the possible contribution of
a greater degree of volume depletion during the mountain
hike.
In conclusion, our study describes physiological differences in
HR and SpO2 during a mountain hike at altitudes from 2,800 to
4,200m compared to a simulated hike in a normobaric hypoxia
chamber. These differences must receive consideration when
high altitude studies are performed or when mountaineers train
for hikes at high altitude using normobaric chambers. The results
of our trial also provide important data for aviation medicine and
intensive care medicine, environments that confront the critical
issue of hypoxia.
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